{"url":"https://lda.senate.gov/api/v1/filings/1f0dac29-6dfe-454f-8dce-7e1da8a4652d/","filing_uuid":"1f0dac29-6dfe-454f-8dce-7e1da8a4652d","filing_type":"2A","filing_type_display":"2nd Quarter - Amendment","filing_year":2020,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/1f0dac29-6dfe-454f-8dce-7e1da8a4652d/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jack S. Deuser, President & CEO","dt_posted":"2020-07-20T17:23:04.680000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1401 K Street NW Suite 1200","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":35800,"url":"https://lda.senate.gov/api/v1/registrants/35800/","house_registrant_id":30770,"name":"THE SMITH-FREE GROUP, LLC","description":"Government relations and business consulting","address_1":"1001 G Street NW","address_2":"Suite 375 West","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JOHN CHRISTIE","contact_telephone":"+1 202-393-4760","dt_updated":"2026-07-30T10:19:36.526196-04:00"},"client":{"id":205949,"url":"https://lda.senate.gov/api/v1/clients/205949/","client_id":1004303,"name":"GVB BIOPHARMA","general_description":"CBD extraction and distillation","client_government_entity":false,"client_self_select":null,"state":"NV","state_display":"Nevada","country":"US","country_display":"United States of America","ppb_state":"NV","ppb_state_display":"Nevada","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-07-01"},"lobbying_activities":[{"general_issue_code":"AGR","general_issue_code_display":"Agriculture","description":"Monitored regulations on hemp/CBD issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63331,"prefix":null,"prefix_display":null,"first_name":"TREVOR","nickname":null,"middle_name":"W.","last_name":"KOLEGO","suffix":null,"suffix_display":null},"covered_position":"Leg. Assistant, Rep. Chris Cannon; Leg. Director, Rep. John Porter; Manager of Member Services, Leader John Boehner; Director of Member Services, Speaker John Boehner","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Discussions relating to the distribution of personal protective equipment.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63331,"prefix":null,"prefix_display":null,"first_name":"TREVOR","nickname":null,"middle_name":"W.","last_name":"KOLEGO","suffix":null,"suffix_display":null},"covered_position":"Leg. Assistant, Rep. Chris Cannon; Leg. Director, Rep. John Porter; Manager of Member Services, Leader John Boehner; Director of Member Services, Speaker John Boehner","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}